Table 1.
Treatment modalities | Drug class | Medications |
---|---|---|
Lifestyle modifications | Nutritional supplements Physical activity Smoking cessation Limited alcohol & caffeine consumption |
Calcium & Vitamin D |
Pharmacological agents (antiresorptive drugs) | BPs | Alendronate, Risedronate, Ibandronate, Zoledronic acid, Clodronate, Minodronate, Pamidronate, Etidronate, Tiludronate |
RANKL antibody | Denosumab | |
Estrogen replacement | Estrogen conjugate | |
SERMs | Raloxifene, Tamoxifene, Lasofoxifene, Bazedoxifene, Arzoxifene | |
Calcitonin | Calcitonin | |
Cathepsin k inhibitors | Odanacatib, Balicatib, ONO-5334 | |
Strontium ranelate | Strontium | |
Pharmacological agents (anabolic drugs) | PTH peptides Anti-sclerostin antibodies |
Teriparatide, PTH 1-84 Romosozumb, Blosozumab, BPS804 |
Legend: BPs Bisphosphonates, SERMs selective estrogen receptor modulator